NVWM LLC’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $71K | Buy |
2,948
+23
| +0.8% | +$602 | 0.01% | 224 |
|
|
2026
Q1 | $82.1K | Sell |
2,925
-25,055
| -90% | -$667K | 0.02% | 227 |
|
|
2025
Q4 | $697K | Buy |
27,980
+25,131
| +882% | +$634K | 0.15% | 152 |
|
|
2025
Q3 | $72.6K | Buy |
2,849
+1,107
| +64% | +$27.3K | 0.02% | 233 |
|
|
2025
Q2 | $42.2K | Buy |
1,742
+160
| +10% | +$3.73K | 0.01% | 253 |
|
|
2025
Q1 | $40.1K | Sell |
1,582
-50
| -3% | -$1.31K | 0.01% | 237 |
|
|
2024
Q4 | $43.3K | Sell |
1,632
-5
| -0.3% | -$136 | 0.01% | 234 |
|
|
2024
Q3 | $47.4K | Buy |
1,637
+18
| +1% | +$525 | 0.01% | 233 |
|
|
2024
Q2 | $45.3K | Buy |
1,619
+58
| +4% | +$1.6K | 0.01% | 235 |
|
|
2024
Q1 | $43.3K | Sell |
1,561
-12,003
| -88% | -$333K | 0.01% | 231 |
|
|
2023
Q4 | $391K | Sell |
13,564
-11,238
| -45% | -$340K | 0.12% | 174 |
|
|
2023
Q3 | $823K | Buy |
24,802
+2,550
| +11% | +$90.2K | 0.27% | 118 |
|
|
2023
Q2 | $816K | Sell |
22,252
-50
| -0.2% | -$1.95K | 0.27% | 123 |
|
|
2023
Q1 | $910K | Buy |
22,302
+3,461
| +18% | +$149K | 0.3% | 98 |
|
|
2022
Q4 | $965K | Sell |
18,841
-151
| -0.8% | -$7.24K | 0.35% | 88 |
|
|
2022
Q3 | $832K | Sell |
18,992
-911
| -5% | -$44.3K | 0.33% | 93 |
|
|
2022
Q2 | $1.04M | Buy |
19,903
+16,197
| +437% | +$825K | 0.41% | 79 |
|
|
2022
Q1 | $192K | Buy |
3,706
+2,236
| +152% | +$116K | 0.06% | 190 |
|
|
2021
Q4 | $87K | Hold |
1,470
| – | – | 0.03% | 227 |
|
|
2021
Q3 | $63K | Hold |
1,470
| – | – | 0.02% | 241 |
|
|
2021
Q2 | $58K | Hold |
1,470
| – | – | 0.02% | 240 |
|
|
2021
Q1 | $53K | Sell |
1,470
-22,303
| -94% | -$792K | 0.02% | 230 |
|
|
2020
Q4 | $875K | Sell |
23,773
-826
| -3% | -$30.3K | 0.36% | 95 |
|
|
2020
Q3 | $857K | Buy |
24,599
+21,571
| +712% | +$756K | 0.4% | 87 |
|
|
2020
Q2 | $94K | Hold |
3,028
| – | – | 0.05% | 157 |
|
|
2020
Q1 | $94K | Sell |
3,028
-81
| -3% | -$2.76K | 0.07% | 148 |
|
|
2019
Q4 | $116K | Sell |
3,109
-25,744
| -89% | -$917K | 0.07% | 150 |
|
|
2019
Q3 | $655K | Buy |
28,853
+10,693
| +59% | +$389K | 0.4% | 85 |
|
|
2019
Q2 | $746K | Sell |
18,160
-13,039
| -42% | -$518K | 0.45% | 66 |
|
|
2019
Q1 | $1.26M | Buy |
31,199
+4,544
| +17% | +$182K | 0.83% | 36 |
|
|
2018
Q4 | $1.1M | Buy |
26,655
+9,219
| +53% | +$383K | 0.83% | 36 |
|
|
2018
Q3 | $729K | Sell |
17,436
-444
| -2% | -$17.1K | 0.46% | 65 |
|
|
2018
Q2 | $615K | Sell |
17,880
-14,564
| -45% | -$498K | 0.43% | 75 |
|
|
2018
Q1 | $1.08M | Buy |
32,444
+1,308
| +4% | +$45K | 0.79% | 38 |
|
|
2017
Q4 | $1.07M | Buy |
+31,136
| New | +$1.06M | 0.82% | 37 |
|
Other funds holding PFE
AIM
SLAM
NVWM LLC's PFE Position: Q2 2026 in Review
NVWM LLC increased its Pfizer (PFE) stake by 0.79% in Q2 2026, buying an estimated $602 and bringing the position to 2,948 shares worth $71K. The position accounts for 0.01% of the portfolio, ranked #224.
NVWM LLC first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.26M in Q1 2019. 1,425 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- NVWM LLC held 2,948 shares of Pfizer worth $71K as of Q2 2026.
- NVWM LLC bought 23 Pfizer shares in Q2 2026, an estimated $602.
- Pfizer made up 0.01% of NVWM LLC's portfolio in Q2 2026, its #224 holding.
- NVWM LLC first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
- NVWM LLC's Pfizer position peaked at $1.26M in Q1 2019.
- 1,425 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on NVWM LLC's 13F filing for Q2 2026, filed 29 Jul 2026.